Evogene (EVGN) –
-
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
-
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
-
EverGen Infrastructure Announces Dates for 2023 Fourth Quarter & Annual Financial Results and Conference Call
-
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
-
Form 6-K Evogene Ltd. For: Apr 02
-
Form EFFECT Evogene Ltd.
-
Form 424B5 Evogene Ltd.
-
Form 6-K Evogene Ltd. For: Mar 28
-
Form 20-F Evogene Ltd. For: Dec 31
-
Evogene Announces Filing of Annual Report on Form 20-F
-
Evogene (EVGN) Receives Nasdaq Non-compliance Notice
-
Form 6-K Evogene Ltd. For: Mar 20
-
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
-
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
-
Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America
-
Evogene (EVGN) Tops Q4 EPS by 1c
-
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
-
Form 6-K Evogene Ltd. For: Mar 07
-
Evogene's (EVGN) AgPlenus Achieves Milestone in Collaboration with Corteva (CTVA)
-
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
-
EverGen Infrastructure Announces Record Single-Day and Monthly Gas Production at the Fraser Valley Biogas Facility
-
Evogene's (EVGN) Casterra Announces New Agreements with Seed Producers in Brazil and Africa
-
Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties
-
Form F-3 Evogene Ltd.
-
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
-
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
-
Evogene's (EVGN) AgPlenus Appoints Dan Jacob Gelvan as CEO
-
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
-
Form 6-K Evogene Ltd. For: Feb 22
-
Form 6-K Evogene Ltd. For: Feb 21
-
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
-
Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide
-
Form SC 13G Evogene Ltd. Filed by: SILVERARC CAPITAL MANAGEMENT, LLC
-
Evogene (EVGN) and Verb Biotics Collaborate to Advance Probiotic Innovation
-
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
-
EverGen Infrastructure Announces Issuance of Shares to the Company’s Board of Directors
-
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
-
Form 6-K Evogene Ltd. For: Jan 17
-
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
-
Form 6-K Evogene Ltd. For: Jan 09
-
EverGen Infrastructure Announces Completion of the Fraser Valley Biogas Expansion and Delivery of First Gas
-
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
-
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
-
Form 6-K Evogene Ltd. For: Dec 19
-
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
-
EverGen Infrastructure Announces Award of 5-Year Compostable Waste Processing Agreement with the City of Abbotsford
-
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
-
EverGen Infrastructure Reports Q3 2023 Results
-
EverGen Infrastructure Announces Dates for 2023 Third Quarter Financial Results and Conference Call
-
Form 6-K Evogene Ltd. For: Nov 15
Back to EVGN Stock Lookup
